C
Catherine Français
Researcher at Bascom Palmer Eye Institute
Publications - 14
Citations - 728
Catherine Français is an academic researcher from Bascom Palmer Eye Institute. The author has contributed to research in topics: Macular degeneration & Fluorescein angiography. The author has an hindex of 9, co-authored 13 publications receiving 545 citations. Previous affiliations of Catherine Français include University of Paris.
Papers
More filters
Journal ArticleDOI
Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome.
Denis Dossarps,Alain M. Bron,Alain M. Bron,Philippe Koehrer,Ludwig S. Aho-Glélé,Catherine Creuzot-Garcher,Catherine Creuzot-Garcher,Laurent Berthon,Quaranta-El Maftouhi,Amina Bakhti,John Conrath,Yannick Le Mer,Christiane Besse Ramahefasolo,Florence Coscas,Catherine Français,Typhaine Grenet,Salomon Y. Cohen,Joel Uzzan,Sam Razavi,Maher Saleh,Bernard Delbosc,G Chaine,Franck Fajnkuchen,Audrey Giocanti,Marie-Noëlle Delyfer,Jean-François Korobelnik,Giuseppe Querques,Olivier Chevreaud,Eric H Souied,Cécile Musson,Christophe Chiquet,Vincent Fortoul,Laurent Kodjikian,Morgane Straub,Carole Burillon,Jean-Paul Berrod,Stéphanie Baillif,Jean-François Girmens,Julien Pérol,Nicolas Leveziel,M. Boissonnot,Marc Muraine,David Gaucher,Marie-Laure Le Lez,Pierre-Jean Pisella +44 more
TL;DR: In this paper, the authors report the incidence and characteristics of endophthalmitis after intravitreal injections of anti-vascular endothelial growth factor agents or corticosteroids and describe the clinical and bacteriologic characteristics, management, and outcome of these eyes with acute endopharthmitis in France.
Journal ArticleDOI
Occult subretinal new vessels in age-related macular degeneration. Natural History and early laser treatment.
TL;DR: In this paper, the authors analyzed the visual and angiographic outcomes in 156 patients with occult neovascularization who were followed for 1 to 8 years and found that early laser treatment decreased visual acuity to less than 20/200 in 31 of the treated eyes (38%) compared with 20 of the untreated eyes (25%).
Journal ArticleDOI
Optical coherence tomography angiography during follow-up: qualitative and quantitative analysis of mixed type I and II choroidal neovascularization after vascular endothelial growth factor trap therapy.
TL;DR: Although FA remains the gold standard for determining the presence of leakage and OCT easily shows fluid accumulation and its variations, OCT-A offers noninvasive monitoring of the retinal and choriocapillaris microvasculature in patients with CNV, aiding in diagnosis and treatment decisions during follow-up.
Journal ArticleDOI
Expanded clinical spectrum of multiple evanescent white dot syndrome with multimodal imaging.
Marcela Marsiglia,Roberto Gallego-Pinazo,Eduardo Cunha de Souza,Marion R. Munk,Su-Quin Yu,Sarah Mrejen,Emmett T. Cunningham,Brandon J. Lujan,Naomi Goldberg,Thomas A. Albini,Alain Gaudric,Catherine Français,Richard B Rosen,K. Bailey Freund,Lee M. Jampol,Lawrence A. Yannuzzi +15 more
TL;DR: Multimodal imaging analysis of the retina in patients with multiple evanescent white dot syndrome shows additional features that may help in the diagnosis of the disease and in further understanding its etiology.
Journal ArticleDOI
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
Jeffrey S. Heier,Carlos Quezada Ruiz,Karen Basu,Christopher Brittain,Marta S. Figueroa,Hugh Lin,Frank G. Holz,Vaibhavi Patel,Timothy Y Y Lai,David Silverman,Carl D. Regillo,Balakumar Swaminathan,Francesco Viola,Chui Ming Gemmy Cheung,Tien Yin Wong,Ashkan M. Abbey,E.B.K Abdulaeva,Prema Abraham,Alfredo Adan Civera,Hansjürgen Agostini,Arturo Alezzandrini,Virgil Alfaro,Arghavan Almony,Lebriz Altay,Payam Amini,Andrew N. Antoszyk,Etelka Aradi,Luis Arias,Jennifer J. Arnold,R H Y Asaria,Sergei Y. Astakhov,Yury S. Astakhov,Carl C. Awh,Chandrakumar Balaratnasingam,Sanjiv Banerjee,Caroline R. Baumal,Matthias D. Becker,Rubens Belfort,G.V. Bratko,William Jr. Z Bridges,Jamin S. Brown,David M. Brown,M.V. Budzinskaya,S. Buffet,Stuart C Burgess,Ik Soo Byon,Carlo Cagini,Jorge I. Calzada,S. Cameron,Peter A. Campochiaro,John Carlson,Angela Carneiro,Clement K. Chan,Emmanuel Chang,Andrew Chang,Daniel Chao,Nauman A Chaudhry,Caroline Chee,Andrew G. Cheek,Shih-Jen Chen,Sanford Chen,Gemmy Cheung,Saradha Chexal,Mark Chittum,David Chow,Abosede Cole,Brian P Connolly,Pierre-Loïc Cornut,Stephen Couvillion,Carl J. Danzig,Vesselin Daskalov,Amr Dessouki,F. Devin,Michael Dollin,R. Dolz,Lois Downey,Richard F. Dreyer,Pravin U. Dugel,David A Eichenbaum,Bora Eldem,R. O. Y. Engstrom,J. J. Escobar,Nicole Eter,David Faber,Naomi S. Falk,Leonard Feiner,Alvaro Fernandez Vega,Philip J. Ferrone,Marta Amaral Figueroa,Howard I. Fine,Mitchell S. Fineman,Gregory M. Fox,Catherine Français,Pablo Franco,Samantha Fraser-Bell,Nicholas S.K. Fung,Federico Sola,Richard O. Gale,Alfredo García-Layana,Julie Gasperini,Maciej Gawęcki,Faruque Ghanchi,Manjot K. Gill,Michael Joseph Giunta,D. Glaser,Michael B. Goldstein,Francisco Gomez Ulla,Fumi Gomi,Víctor González,Jordan M. Graff,Sunil Gupta,Rainer Guthoff,Robyn H. Guymer,Anton Haas,Robert Tudor. Hampton,Katja Hatz,Ken Hayashi,Ewa Herba,Vrinda S. Hershberger,Patrick Higgins,Nancy M. Holekamp,Shigeru Honda,James Andrew Howard,Allen Hu,Stephen M. Huddleston,Tomohiro Iida,Hiroko Imaizumi,Yasuo Ito,Yasuki Ito,Sujit Itty,Golnaz Javey,Cameron Javid,Tatsushi Kaga,Jakub J. Kaluzny,Se Woong Kang,Kapil Kapoor,Levent Karabaş,Tsutomu Kawasaki,Patrick J. Kelty,Ágnes Kerényi,Arshad M. Khanani,Ramin Khoramnia,Rahul N. Khurana,Kazuhiro Kimura,Kendra Klein-Mascia,Namie Kobayashi,Laurent Kodjikian,Hideki Koizumi,Gregg T. Kokame,Alexey Kulikov,Henry Kwong,R. Kwun,Chi-Chun Lai,L Lalonde,Paolo Lanzetta,Michael Larsen,Adrian M. Lavina,Won Ki Lee,Ji Eun Lee,Seong Cheol Lee,Jaim Atri Levy,Luke B. Lindsell,Mimi Liu,N.J. London,Andrew J. Lotery,D. Lozano Rechy,Alan Luckie,David Maberley,Takatoshi Maeno,Sajjad Mahmood,Fuad Makkouk,Dennis M. Marcus,Alan R. Margherio,H. Masse,Hisashi Matsubara,Raj K. Maturi,Sonia Mehta,Geeta Menon,Jale Menteş,Mark Michels,Yoshinori Mitamura,Paul Mitchell,Quresh Mohamed,Jordi Monés,Rodrigo Montemayor Lobo,Javier Montero,Jeffrey Thomas Moore,Ryusaburo Mori,Haia Morori-Katz,Raj Mukherjee,Toshinori Murata,Maria Muzyka-Woźniak,Marco Nardi,Nirodhini Narendran,Massimo Nicolò,Jared S. Nielsen,Tetsuya Nishimura,Kousuke Noda,Anna Nowińska,Hideyasu Oh,Matthew Ohr,Annabelle A. Okada,Piotr Oleksy,Shinji Ono,Sengul Ozdek,Banu Ozturk,Luisito S. Pablo,Kyu Hyung Park,Darrel W. Parke,Mariacristina Parravano,Praveen J Patel,Apurva Patel,Sunil S. Patel,Sugat Patel,Daniel Pauleikhoff,Ian Pearce,Joel Pearlman,Iva Petkova,Dante J. Pieramici,N. A. Pozdeyeva,Jawad Qureshi,Dorota Raczyńska,Juan Abel Ramírez Estudillo,R Rathod,Hessamoddin Meshkat Razavi,Gayatri Reilly,Federico Ricci,Ryan M. Rich,Bożena Romanowska-Dixon,Irit Rosenblatt,José María Moreno,Stefan Sacu,Habiba Saedon,Usman Saeed,Min Sagong,Taiji Sakamoto,Sukhpal S Sandhu,Laura Sararols,Mario Saravia,Ramin Schadlu,Patricio G. Schlottmann,Tetsuju Sekiryu,Andras Seres,Figen Şermet,Sumit P Shah,Rohan Shiloh Shah,Ankur S. Shah,Tom G. Sheidow,Veeral S. Sheth,Chieko Shiragami,Bartosz L. Sikorski,Rufino Silva,Lawrence J. Singerman,R. C. Sisk,Torben Lykke Sørensen,Eric H Souied,David J. Spinak,Giovanni Staurenghi,Robert R. Steinmetz,Glenn L. Stoller,Robert E. Stoltz,Eric P. Suan,Ivan J. Suñer,Y. O'Reilly Suzanne,Ramin Tadayoni,Kanji Takahashi,Kenji Takayama,Alexandre Chater Taleb,James S Talks,Hiroko Terasaki,John Thompson,Edit Tóth-Molnár,Khoi Tran,Raman Tuli,E. Uchiyama,Attila Vajas,Janneke Van Lith-Verhoeven,Balázs Varsányi,Gianni Virgili,Gábor Vogt,Michael Völker,David Warrow,Pamela Weber,John A. Wells,Sanjeewa S. Wickremasinghe,Mark R. Wieland,Geoff Williams,Thomas Williams,David Wong,King Chong. Wong,James Wai Keat Wong,Ian Y. H. Wong,Robert Kin Ming Wong,Bogumil Wowra,Charles C. Wykoff,Ayana Yamashita,Kanako Yasuda,Gürsel Yilmaz,Glenn Yiu,Ai Yoneda,Young Hee Yoon,Barak Yoreh,HyeongGon Yu,Seung-Young Yu,Tatiana S. Yurieva,Alberto Zambrano,Barbara Zatorska,C. Zeolite +307 more
TL;DR: Visual benefits with faricimab given at up to 16-week intervals demonstrates its potential to meaningfully extend the time between treatments with sustained efficacy, thereby reducing treatment burden in patients with nAMD.